Mice with a CML-like disease relapse with an acute lymphocytic leukemia after treatment with STI571.

被引:0
|
作者
Miething, C [1 ]
Grundler, R [1 ]
Hoepfl, J [1 ]
Mugler, C [1 ]
Peschel, C [1 ]
Duyster, J [1 ]
机构
[1] Klinikum Rechts Der Isar, Dept Med 3, Munich, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2985
引用
收藏
页码:714A / 715A
页数:2
相关论文
共 50 条
  • [1] Mice with a CML-like disease relapse with ALL under STI571 treatment
    Miething, C
    Grundler, R
    Hoepfl, J
    Mugler, C
    Gschaidmeier, H
    Peschel, C
    Duyster, J
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 96 - 96
  • [2] The chromosomal complexity score (CCS) as a predictive factor for response of patients with CML in accelerated phase to treatment with STI571.
    Marin, D
    Bua, M
    Marktel, S
    Chase, A
    Armstrong, L
    Udom, C
    Olavarria, E
    Apperley, JF
    Goldman, JM
    BLOOD, 2001, 98 (11) : 262B - 262B
  • [3] Successful allogeneic transplantation after treatment of blast crisis CML with STI571
    Deininger, MWN
    Schäfer, K
    Sayer, H
    Russel, N
    Peschel, C
    Gratwohl, A
    Goldman, J
    Hochhaus, A
    Guilhot, F
    Gambacorti-Passerini, C
    O'Brian, S
    Arcese, W
    Kolb, H
    AlAli, H
    Hegenbart, U
    Lange, T
    Capdeville, R
    Niederwieser, D
    BONE MARROW TRANSPLANTATION, 2001, 27 : S37 - S38
  • [4] Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571
    Baron, F
    Frère, P
    Fillet, G
    Beguin, Y
    HAEMATOLOGICA, 2001, 86 (09) : 993 - 994
  • [5] Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation
    Olavarria, E
    Craddock, C
    Dazzi, F
    Marin, D
    Marktel, S
    Apperley, JF
    Goldman, JM
    BLOOD, 2002, 99 (10) : 3861 - 3862
  • [6] Complete remission of third recurrence of acute myeloid leukemia after treatment with Imatinib (STI-571)
    Schittenhelm, M
    Aichele, O
    Kröber, SM
    Brümmendorf, T
    Kanz, L
    Denzlinger, C
    LEUKEMIA & LYMPHOMA, 2003, 44 (07) : 1251 - 1253
  • [7] Treatment of chronic myeloid leukemia (CML) with STI571 in patients age ≥60 years.
    Cortes, J
    Talpaz, M
    O'Brien, SM
    Manero, G
    Thomas, D
    Faderl, S
    Capdeville, R
    Kantarjian, HM
    BLOOD, 2001, 98 (11) : 256B - 256B
  • [8] Glivec(STI571) treatment for chronic myelogenous leukemia (CML) in relapse after allogeneic stem cell transplantation (SCT): A report of the French experience (on behalf of the SFGM and FILMC).
    Chambon-Pautas, C
    Cony-Makhoul, P
    Giraudier, S
    Vigier, M
    Michallet, M
    Guilhot, F
    Jouet, JP
    Berthaud, P
    Kuentz, M
    BLOOD, 2001, 98 (11) : 140A - 140A
  • [9] Imatinib (STI-571) for treatment of relapse after stem cell transplantation (SCT).
    Miller, CB
    Smith, BD
    Gore, SD
    Dolan, S
    Yerian, JA
    Hartley, EE
    Koehler, J
    Topolsky, D
    O'Donnell, P
    Jones, RJ
    BLOOD, 2001, 98 (11) : 400A - 401A
  • [10] Treatment of adult patients with acute lymphocytic leukemia in relapse
    Mazza, JJ
    Leong, T
    Rowe, JM
    Wiernik, PH
    Cassileth, PA
    LEUKEMIA & LYMPHOMA, 1996, 20 (3-4) : 317 - 319